Company Valuation: eFFECTOR Therapeutics, Inc.

Data adjusted to current consolidation scope
Fiscal Period: December 2021 2022 2023
Market Cap 1 334.3 17.91 30.2
Change - -94.64% 68.61%
Enterprise Value (EV) 1 304.6 11.88 32.38
Change - -96.1% 172.45%
P/E 18.8x -0.78x -0.71x
PBR 19.3x 4.58x -6.01x
PEG 0x 0x -0x
Capitalization / Revenue 233,760,757x 5,041,796x -
EV / Revenue - - -
EV / EBITDA -9.56x -0.37x -0.96x
EV / EBIT -9.55x -0.37x -0.96x
EV / FCF - - -
FCF Yield - - -
Dividend per Share 2 - - -
Rate of return - - -
EPS 2 11 -13.76 -16.37
Distribution rate - - -
Net sales 1.43 3.553 -
EBITDA 1 -31.87 -32.35 -33.73
EBIT 1 -31.9 -32.4 -33.84
Net income 1 15.8 -22.66 -35.81
Net Debt 1 -29.67 -6.029 2.175
Reference price 2 207.000000 10.690000 11.685000
Nbr of stocks (in thousands) 1,615 1,676 2,585
Announcement Date 3/16/22 3/8/23 3/26/24
1USD in Million2USD
Estimates

P/E (N) EV / Sales (N) EV / EBITDA (N) Dividend Yield (N) Capi.($)
- - - - 940
21.08x6.49x14.2x1.51% 55.92B
33.57x8.33x25.41x0.06% 56.67B
-18.45x4.44x-7.77x-.--% 23.28B
-42.05x13.36x-39.35x-.--% 23.28B
25.7x5.07x13.38x-.--% 20.54B
24.87x4.83x15.68x-.--% 17.78B
-617.89x37.85x-1571.42x-.--% 15.9B
44.16x17.85x45.97x0.08% 14.64B
17.51x5.07x11.83x-.--% 13.99B
Average -56.83x 11.48x -165.79x 0.18% 24.2B
Weighted average by Cap. -25.98x 9.81x -92.78x 0.37%

Y-o-Y evolution of P/E

Historical PBR trend

Evolution Enterprise Value / Sales

Change in Enterprise Value/EBITDA

  1. Stock Market
  2. Stocks
  3. EFTR Stock
  4. Valuation eFFECTOR Therapeutics, Inc.